Maryland biotech Altimmune Inc. has reached an agreement to acquire California drug developer Spitfire Pharma Inc. in a move that sent the local company’s stock skyrocketing Tuesday.
{iframe}https://www.bizjournals.com/washington/news/2019/07/09/altimmune-to-acquire-california-company-for-up-to.html{/iframe}